NPR: JN.1 takes over as the most prevalent COVID-19 variant. Here’s what you need to know

237

A new variant of COVID-19 has spiked, making up 86% of cases in the country. The variant, JN.1, has surged due to a lack of COVID-19 vaccinations and because our immune systems haven’t been able to keep up. The most recent vaccinations from Pfizer-BioNTech, Moderna, and Novavax are all expected to help lower the chances of serious illness or hospitalization from JN.1.

To read the full article by Vanessa Romo, click here.

Comments are closed.

Skip to toolbar